Bisphosphonate treatment does not affect serum levels of osteoprotegerin and RANKL in hypercalcemic cancer patients

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

Details

Original languageUndefined
JournalAnticancer research
Publication statusPublished - 2005
Peer-reviewedYes

External IDs

WOS 000231077600067
Scopus 23344445607

Keywords

Sustainable Development Goals